• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肌肉浸润性膀胱癌的蛋白质相互作用组

Protein interactome of muscle invasive bladder cancer.

作者信息

Bhat Akshay, Heinzel Andreas, Mayer Bernd, Perco Paul, Mühlberger Irmgard, Husi Holger, Merseburger Axel S, Zoidakis Jerome, Vlahou Antonia, Schanstra Joost P, Mischak Harald, Jankowski Vera

机构信息

Charité-Universitätsmedizin Berlin, Med. Klinik IV, Berlin, Germany; Mosaiques diagnostics GmbH, Hannover, Germany.

emergentec biodevelopment GmbH, Vienna, Austria.

出版信息

PLoS One. 2015 Jan 8;10(1):e0116404. doi: 10.1371/journal.pone.0116404. eCollection 2015.

DOI:10.1371/journal.pone.0116404
PMID:25569276
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4287622/
Abstract

Muscle invasive bladder carcinoma is a complex, multifactorial disease caused by disruptions and alterations of several molecular pathways that result in heterogeneous phenotypes and variable disease outcome. Combining this disparate knowledge may offer insights for deciphering relevant molecular processes regarding targeted therapeutic approaches guided by molecular signatures allowing improved phenotype profiling. The aim of the study is to characterize muscle invasive bladder carcinoma on a molecular level by incorporating scientific literature screening and signatures from omics profiling. Public domain omics signatures together with molecular features associated with muscle invasive bladder cancer were derived from literature mining to provide 286 unique protein-coding genes. These were integrated in a protein-interaction network to obtain a molecular functional map of the phenotype. This feature map educated on three novel disease-associated pathways with plausible involvement in bladder cancer, namely Regulation of actin cytoskeleton, Neurotrophin signalling pathway and Endocytosis. Systematic integration approaches allow to study the molecular context of individual features reported as associated with a clinical phenotype and could potentially help to improve the molecular mechanistic description of the disorder.

摘要

肌肉浸润性膀胱癌是一种复杂的多因素疾病,由多种分子途径的破坏和改变引起,导致异质性表型和可变的疾病结局。整合这些不同的知识可能为解读与分子特征指导的靶向治疗方法相关的分子过程提供见解,从而改善表型分析。本研究的目的是通过纳入科学文献筛选和组学分析特征,在分子水平上对肌肉浸润性膀胱癌进行表征。通过文献挖掘获得了公共领域的组学特征以及与肌肉浸润性膀胱癌相关的分子特征,从而提供了286个独特的蛋白质编码基因。这些基因被整合到一个蛋白质相互作用网络中,以获得该表型的分子功能图谱。该特征图谱基于三条可能与膀胱癌相关的新疾病相关途径构建,即肌动蛋白细胞骨架调节、神经营养因子信号通路和内吞作用。系统整合方法有助于研究报告为与临床表型相关的个体特征的分子背景,并可能有助于改善对该疾病分子机制的描述。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c2da/4287622/586f22b66bc8/pone.0116404.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c2da/4287622/8528c4889f8e/pone.0116404.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c2da/4287622/94ee8024910d/pone.0116404.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c2da/4287622/71948e1928d7/pone.0116404.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c2da/4287622/586f22b66bc8/pone.0116404.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c2da/4287622/8528c4889f8e/pone.0116404.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c2da/4287622/94ee8024910d/pone.0116404.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c2da/4287622/71948e1928d7/pone.0116404.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c2da/4287622/586f22b66bc8/pone.0116404.g004.jpg

相似文献

1
Protein interactome of muscle invasive bladder cancer.肌肉浸润性膀胱癌的蛋白质相互作用组
PLoS One. 2015 Jan 8;10(1):e0116404. doi: 10.1371/journal.pone.0116404. eCollection 2015.
2
Inhibition of STAT signalling in bladder cancer by diindolylmethane: relevance to cell adhesion, migration and proliferation.二吲哚甲烷抑制膀胱癌中 STAT 信号传导:与细胞黏附、迁移和增殖的相关性。
Curr Cancer Drug Targets. 2013 Jan;13(1):57-68.
3
Copper Transporter-CTR1 Expression and Pathological Outcomes in Platinum-treated Muscle-invasive Bladder Cancer Patients.铜转运蛋白CTR1在铂类治疗的肌层浸润性膀胱癌患者中的表达及病理结果
Anticancer Res. 2016 Feb;36(2):495-501.
4
SNAI1 protein expression is an independent negative prognosticator in muscle-invasive bladder cancer.SNAI1 蛋白表达是肌层浸润性膀胱癌的独立预后不良因素。
Ann Surg Oncol. 2013 Oct;20(11):3669-74. doi: 10.1245/s10434-013-3075-6. Epub 2013 Jun 27.
5
Interleukin-5 enhances the migration and invasion of bladder cancer cells via ERK1/2-mediated MMP-9/NF-κB/AP-1 pathway: involvement of the p21WAF1 expression.白细胞介素-5 通过 ERK1/2 介导的 MMP-9/NF-κB/AP-1 通路增强膀胱癌细胞的迁移和侵袭:涉及 p21WAF1 的表达。
Cell Signal. 2013 Oct;25(10):2025-38. doi: 10.1016/j.cellsig.2013.06.004. Epub 2013 Jun 11.
6
Key signaling pathways in the muscle-invasive bladder carcinoma: Clinical markers for disease modeling and optimized treatment.肌肉浸润性膀胱癌中的关键信号通路:疾病建模和优化治疗的临床标志物。
Int J Cancer. 2016 Jun 1;138(11):2562-9. doi: 10.1002/ijc.29918. Epub 2015 Nov 23.
7
Regularly methylated novel pro-apoptotic genes associated with recurrence in transitional cell carcinoma of the bladder.与膀胱移行细胞癌复发相关的新型促凋亡基因的定期甲基化
Int J Cancer. 2006 Sep 15;119(6):1396-402. doi: 10.1002/ijc.21971.
8
Histologic tumor growth pattern is significantly associated with disease-related survival in muscle-invasive transitional cell carcinoma of the urinary bladder.组织学肿瘤生长模式与膀胱肌层浸润性移行细胞癌的疾病相关生存率显著相关。
Oncol Rep. 2004 Sep;12(3):609-13.
9
A novel role for drebrin in regulating progranulin bioactivity in bladder cancer.肌动蛋白结合蛋白在调节膀胱癌中颗粒前体生物活性方面的新作用。
Oncotarget. 2015 May 10;6(13):10825-39. doi: 10.18632/oncotarget.3424.
10
Independent predictors of cancer-specific survival in transitional cell carcinoma of the upper urinary tract: multi-institutional dataset from 3 European centers.上尿路移行细胞癌患者癌症特异性生存的独立预测因素:来自3个欧洲中心的多机构数据集
Cancer. 2007 Oct 15;110(8):1715-22. doi: 10.1002/cncr.22970.

引用本文的文献

1
Proteomics analysis of bladder cancer invasion: Targeting EIF3D for therapeutic intervention.膀胱癌侵袭的蛋白质组学分析:以EIF3D为靶点进行治疗干预。
Oncotarget. 2017 Apr 20;8(41):69435-69455. doi: 10.18632/oncotarget.17279. eCollection 2017 Sep 19.
2
Ten Years of Proteomics in Bladder Cancer: Progress and Future Directions.膀胱癌蛋白质组学十年:进展与未来方向
Bladder Cancer. 2017 Jan 27;3(1):1-18. doi: 10.3233/BLC-160073.
3
BcCluster: A Bladder Cancer Database at the Molecular Level.BcCluster:一个分子水平的膀胱癌数据库。

本文引用的文献

1
Clinical proteomic biomarkers: relevant issues on study design & technical considerations in biomarker development.临床蛋白质组学标志物:在生物标志物开发的研究设计和技术考虑方面的相关问题。
Clin Transl Med. 2014 Mar 29;3(1):7. doi: 10.1186/2001-1326-3-7.
2
Comprehensive molecular characterization of urothelial bladder carcinoma.尿路上皮膀胱癌的综合分子特征分析
Nature. 2014 Mar 20;507(7492):315-22. doi: 10.1038/nature12965. Epub 2014 Jan 29.
3
A pilot study using next-generation sequencing in advanced cancers: feasibility and challenges.
Bladder Cancer. 2016 Jan 7;2(1):65-76. doi: 10.3233/BLC-150024.
4
Integrative analysis of extracellular and intracellular bladder cancer cell line proteome with transcriptome: improving coverage and validity of -omics findings.膀胱癌细胞系细胞外和细胞内蛋白质组与转录组的综合分析:提高组学研究结果的覆盖范围和有效性。
Sci Rep. 2016 May 11;6:25619. doi: 10.1038/srep25619.
5
Vascular endothelial growth factor A as predictive marker for mTOR inhibition in relapsing high-grade serous ovarian cancer.血管内皮生长因子A作为复发性高级别浆液性卵巢癌中mTOR抑制的预测标志物。
BMC Syst Biol. 2016 Apr 18;10:33. doi: 10.1186/s12918-016-0278-z.
6
Characteristics of Patients With Transitional Cell Carcinoma of the Urinary Bladder in Kermanshah Province, Iran.伊朗克尔曼沙阿省膀胱移行细胞癌患者的特征
Iran J Cancer Prev. 2015 Dec;8(6):e4038. doi: 10.17795/ijcp-4038. Epub 2015 Dec 23.
7
Molecular Architecture of Spinal Cord Injury Protein Interaction Network.脊髓损伤蛋白相互作用网络的分子结构
PLoS One. 2015 Aug 4;10(8):e0135024. doi: 10.1371/journal.pone.0135024. eCollection 2015.
一项在晚期癌症中使用下一代测序的初步研究:可行性和挑战。
PLoS One. 2013 Oct 30;8(10):e76438. doi: 10.1371/journal.pone.0076438. eCollection 2013.
4
Searching for urine biomarkers of bladder cancer recurrence using a liquid chromatography-mass spectrometry and capillary electrophoresis-mass spectrometry metabolomics approach.采用液相色谱-质谱联用和毛细管电泳-质谱代谢组学方法寻找膀胱癌复发的尿液生物标志物。
J Chromatogr A. 2013 Nov 29;1318:163-70. doi: 10.1016/j.chroma.2013.10.002. Epub 2013 Oct 4.
5
Alterations of DNA methylome in human bladder cancer.人类膀胱癌中 DNA 甲基组的改变。
Epigenetics. 2013 Oct;8(10):1013-22. doi: 10.4161/epi.25927. Epub 2013 Aug 6.
6
Bioinformatics analysis of the gene expression profile in Bladder carcinoma.膀胱癌基因表达谱的生物信息学分析。
Genet Mol Biol. 2013 Jul;36(2):287-91. doi: 10.1590/S1415-47572013005000015. Epub 2013 Apr 12.
7
Diagnostic markers of urothelial cancer based on DNA methylation analysis.基于 DNA 甲基化分析的尿路上皮癌诊断标志物。
BMC Cancer. 2013 Jun 4;13:275. doi: 10.1186/1471-2407-13-275.
8
ATF3 suppresses metastasis of bladder cancer by regulating gelsolin-mediated remodeling of the actin cytoskeleton.转录激活因子 3 通过调控凝溶胶蛋白介导的细胞骨架重构抑制膀胱癌转移。
Cancer Res. 2013 Jun 15;73(12):3625-37. doi: 10.1158/0008-5472.CAN-12-3879. Epub 2013 Mar 27.
9
Network views for personalized medicine.网络视角下的个性化医疗。
Proteomics Clin Appl. 2013 Jun;7(5-6):384-7. doi: 10.1002/prca.201200121. Epub 2013 May 10.
10
Selective regulation of p38β protein and signaling by integrin-linked kinase mediates bladder cancer cell migration.整合素连接激酶对 p38β 蛋白和信号的选择性调节介导膀胱癌细胞迁移。
Oncogene. 2014 Feb 6;33(6):690-701. doi: 10.1038/onc.2013.20. Epub 2013 Feb 25.